Investment banks can mitigate risk in the over-the-counter markets by standardising pricing practices, according to a new report, as regulators seek to force the adoption of clearing houses to reduce counterparty risk.

According to a paper published today by research house Celent, investment firms cannot afford to allow continued fragmentation in the way OTC derivative prices are set in the front office and should move to a common approach to pricing.